Alcon ALC 深 沪
等待开盘 10-26 09:30:00 美东时间
70.17
-0.460
-0.65%
华盛通- 最 高70.46
- 今 开70.16
- 成交量 259.24万股
- 最 低 69.54
- 昨 收 70.63
- 总市值 3392.02万
- 52周最高 87.2806
- 市盈率 静 35.53
- 换手率 536.29%
- 52周最低 61.835
- 委 比 57.89%
- 总股本 0.00亿
- 历史最高 100.407
- 量 比 1.89
- 振 幅 1.30%
- 历史最低 37.8618
- 每 手 1
- 风险率 6.05%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅227.21%！Jones Trading上调Rapport Therapeutics(RAPP)目标价至82美元，维持"买入"评级
今日重点评级关注：Jones Trading：维持Rapport Therapeutics"买入"评级，目标价从50美元升至82美元；摩根大通：维持SpaceX"超配"评级，目标价从240美元升至500美元
10-22 11:59
Needham Reiterates Buy on Alcon, Maintains $98 Price Target
Needham analyst David Saxon reiterates Alcon (NYSE:ALC) with a Buy and maintains $98 price target.
10-21 19:20
Alcon Acquires Neurotech Pharmaceuticals For $550M
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired Neurotech Pharmaceuticals, Inc., a company focused on developing innovative cell therapies for chronic and neurodegenerative eye diseases. This acquisition expands Alcon'...
10-21 04:36
Alcon Announces FDA Approval For BRYTLY Redness Relief Eye Drops, Expanding Over The Counter Eye Care Portfolio.
One drop works to significantly reduce redness, with results lasting up to 12 hours1 Lasts up to 50% longer than Lumify1-2,* Expands Alcon's portfolio of consumer eye care solutions and will be available in major retailers nationwide and online in the coming months Alcon (NYSE:ALC), the global leade...
10-17 03:59
Why Is Sight Sciences Stock Gaining Thursday?
Sight Sciences, Inc. (NASDAQ:SGHT) stock gained Thursday after H.C. Wainwright initiated coverage with a Buy rating and a $14 price forecast. Analyst Yi Chen sees upside potential from the medical device company’s expanding glaucoma and dry eye treatment businesses, supported by improving operating ...
10-16 01:53
美股大行评级 | 潜在涨幅175.74%！美光科技获DA Davidson上调目标价至3000美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持美光科技"买入"评级，目标价从2100美元升至3000美元；Leerink Partners：维持OmniAb"跑赢大市"评级，目标价从10美元升至12美元
10-08 12:30
Barclays Initiates Coverage On Alcon with Equal-Weight Rating, Announces Price Target of $70
Barclays analyst Christopher Pasquale initiates coverage on Alcon (NYSE:ALC) with a Equal-Weight rating and announces Price Target of $70.
10-07 20:07
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Alcon (ALC)
Companies in the Healthcare sector have received a lot of coverage today as ana...
09-23 14:50
医械巨头，在华重大投资
9月18日，据中国日报报道，进入中国三十余年的全球眼健康企业爱尔康（Alcon）宣布将加大在华投资、深化本地化。 爱尔康中国区总裁Rick Kozloski表示...
09-21 14:28
